UBS Group AG - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 97 filers reported holding G1 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$307
-95.5%
213
-92.2%
0.00%
Q2 2023$6,757
-60.0%
2,714
-56.9%
0.00%
Q1 2023$16,887
-61.0%
6,301
-21.1%
0.00%
Q4 2022$43,348
-93.8%
7,983
-85.7%
0.00%
Q3 2022$700,000
+69900.0%
55,983
+26183.1%
0.00%
Q2 2022$1,000
-99.9%
213
-99.9%
0.00%
-100.0%
Q1 2022$1,694,000
-35.6%
222,919
-13.5%
0.00%0.0%
Q4 2021$2,631,000
+62.6%
257,719
+113.8%
0.00%0.0%
Q3 2021$1,618,000
+383.0%
120,562
+688.6%
0.00%
Q2 2021$335,000
-79.0%
15,288
-77.0%
0.00%
-100.0%
Q1 2021$1,599,000
+39875.0%
66,471
+31107.0%
0.00%
Q4 2020$4,000
-93.3%
213
-95.9%
0.00%
Q3 2020$60,000
+57.9%
5,213
+233.1%
0.00%
Q2 2020$38,000
-67.8%
1,565
-85.4%
0.00%
Q1 2020$118,000
-83.7%
10,726
-60.9%
0.00%
Q4 2019$725,000
-52.2%
27,410
-58.9%
0.00%
-100.0%
Q3 2019$1,518,000
+189.7%
66,671
+290.5%
0.00%
Q2 2019$524,000
+4266.7%
17,073
+2294.5%
0.00%
Q1 2019$12,000
-99.3%
713
-99.2%
0.00%
-100.0%
Q4 2018$1,803,000
+344.1%
94,141
+1113.0%
0.00%
Q3 2018$406,000
+327.4%
7,761
+253.9%
0.00%
Q2 2018$95,000
+137.5%
2,193
+99.4%
0.00%
Q1 2018$40,000
+48.1%
1,100
-18.8%
0.00%
Q4 2017$27,000
+170.0%
1,354
+238.5%
0.00%
Q3 2017$10,000
-33.3%
400
-55.3%
0.00%
Q2 2017$15,0008950.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Birchview Capital, LP 120,000$172,8000.15%
DENALI ADVISORS LLC 148,800$214,2720.08%
XTX Topco Ltd 296,601$427,1050.07%
NEEDHAM INVESTMENT MANAGEMENT LLC 234,000$336,9600.06%
LEVEL FOUR ADVISORY SERVICES, LLC 183,400$264,0960.02%
Curi Wealth Management, LLC 70,742$101,8690.02%
FRANKLIN STREET ADVISORS INC /NC 83,400$1200.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 140,000$201,6000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 573,256$825,4890.01%
ALGERT GLOBAL LLC 68,100$980.01%
View complete list of G1 THERAPEUTICS INC shareholders